Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38144
CAS Number:
129029-23-8
Ocapéridone
Purity:
≥ 98 % (HPLC)
Synonym(s):
3-[2-[4-(6-fluorobenzo[d]isoxazol-3-yl)pipéridin-1-yl]éthyl]-2,9-diméthyl-4 H -pyrido[1,2-a]pyrimidin-4-one
Documents
$208.31 /25 mg
Taille
Request Bulk Quote
Informations sur le produit

Ocaperidone is a novel antipsychotic agent that has garnered attention for its potential in treating various psychiatric disorders. This compound is characterized by its unique structure, which includes a piperidine moiety and a fluorobenzoxazole group, contributing to its efficacy and specificity in targeting dopamine receptors. Ocaperidone's pharmacological profile suggests it may offer advantages over traditional antipsychotics, particularly in minimizing side effects commonly associated with this class of medications.

In clinical research, Ocaperidone has shown promise in managing symptoms of schizophrenia and other mood disorders, making it a valuable candidate for further development in psychiatric therapeutics. Its ability to modulate neurotransmitter activity while maintaining a favorable safety profile positions it as a potential alternative for patients who are resistant to existing treatments. Researchers and industry professionals can explore Ocaperidone's applications in drug formulation and development, as well as its role in advancing mental health therapies.

Numéro CAS 
129029-23-8
Formule moléculaire
C24H25FN4O2
Poids moléculaire 
420.49
Point de fusion 
180 - 184 °C
Informations générales
Numéro CAS 
129029-23-8
Formule moléculaire
C24H25FN4O2
Poids moléculaire 
420.49
Point de fusion 
180 - 184 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Ocaperidone is widely utilized in research focused on:

  • Antipsychotic Treatments: This compound is primarily used in the development of medications for treating schizophrenia and other psychotic disorders, offering a new avenue for patients who may not respond to traditional therapies.
  • Neuroscience Research: Researchers use ocaperidone to study its effects on neurotransmitter systems, which can lead to a better understanding of brain function and the development of new therapeutic strategies.
  • Pharmaceutical Formulations: The compound is incorporated into various formulations, enhancing the efficacy of antipsychotic drugs while potentially reducing side effects compared to older medications.
  • Clinical Trials: Ocaperidone is being evaluated in clinical trials for its safety and effectiveness, providing valuable data that can inform future treatment protocols and guidelines.
  • Comparative Studies: It serves as a reference compound in studies comparing the pharmacological profiles of new antipsychotic agents, helping to identify promising candidates for further development.

Citations